REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME

This adverse event was reported 1976 times

These drugs are most commonly taken by patients reporting REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME:

# Drug Count
0 ESCITALOPRAM 172
1 ESCITALOPRAM OXALATE 169
2 METHYLPREDNISOLONE 167
3 FLUOXETINE HYDROCHLORIDE 165
4 ESCITSLOPRAM 152
5 TACROLIMUS 145
6 MYCOPHENOLATE MOFETIL 138
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 138
8 FLUOXETINE 135
9 TACROLIMUS EXTENDED-RELEASE CAPSULES 124
See all common drugs associated with REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME

REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIMODIPINE 31 0.0276
1 SUMATRIPTAN SUCCINATE 119 0.0046
2 NOREPINEPHRINE BITARTRATE 42 0.0028
3 CABERGOLINE 14 0.0028
4 SUMATRIPTAN 107 0.0028
5 ZOLMITRIPTAN 20 0.0028
6 BASILIXIMAB 31 0.0026
7 ACETAMINOPHEN, ASPRIN, CAFFEINE 18 0.0025
8 ACETAMINOPHEN, ASPIRIN (NSAID), CAFFEINE 18 0.0025
9 AMISULPRIDE 14 0.0023
See all drugs enriched for association with REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME